These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 11140468)
1. Is lack of peripheral tolerance induction a cause for diabetes in the non-obese diabetic mouse? Lund T; Strid J Arch Immunol Ther Exp (Warsz); 2000; 48(5):405-16. PubMed ID: 11140468 [TBL] [Abstract][Full Text] [Related]
2. Genetic and immunological basis of autoimmune diabetes in the NOD mouse. Yoshida K; Kikutani H Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686 [TBL] [Abstract][Full Text] [Related]
3. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice. Boudaly S; Morin J; Berthier R; Marche P; Boitard C Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018 [TBL] [Abstract][Full Text] [Related]
4. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice. Mellanby RJ; Phillips JM; Parish NM; Cooke A Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644 [TBL] [Abstract][Full Text] [Related]
6. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice. Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281 [TBL] [Abstract][Full Text] [Related]
7. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse. Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260 [TBL] [Abstract][Full Text] [Related]
8. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Cardell SL Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Lo J; Clare-Salzler MJ Autoimmun Rev; 2006 Jul; 5(6):419-23. PubMed ID: 16890897 [TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 60 elicits abnormal response in macrophages of diabetes-prone non-obese diabetic mice. Adler T; Akiyama H; Herder C; Kolb H; Burkart V Biochem Biophys Res Commun; 2002 Jun; 294(3):592-6. PubMed ID: 12056808 [TBL] [Abstract][Full Text] [Related]
11. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model. Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243 [TBL] [Abstract][Full Text] [Related]
12. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related]
13. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype. Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387 [TBL] [Abstract][Full Text] [Related]
14. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923 [TBL] [Abstract][Full Text] [Related]
15. CD3 antibody treatment stimulates the functional capability of regulatory T cells. Chatenoud L Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225 [TBL] [Abstract][Full Text] [Related]
16. Lessons on autoimmune diabetes from animal models. Yang Y; Santamaria P Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681 [TBL] [Abstract][Full Text] [Related]
17. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes. Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547 [TBL] [Abstract][Full Text] [Related]
18. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice. Peng RH; Paek E; Xia CQ; Tennyson N; Clare-Salzler MJ Ann N Y Acad Sci; 2006 Oct; 1079():99-102. PubMed ID: 17130537 [TBL] [Abstract][Full Text] [Related]
19. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. MariƱo E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Li AF; Hough J; Henderson D; Escher A Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]